β blockers to prevent decompensation of cirrhosis in patients with clinically signi cant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
Aggiungi ai preferiti : permalink.
CLEO » Articoli » β blockers to prevent decompensation of cirrhosis in patients with clinically signi cant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial